Very poorly explained and quantified. Given the lack of transparency around the "one off expenses" and "expected" R&D recoveries no wonder there are cash concerns and a sell down. P1ss poor communications.
Ann: Quarterly Appendix 4C and Activities Report, page-65
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $211.7M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 38.5¢ | 37.3¢ | $415.7K | 1.097M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 140000 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 18118 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |